In the context of cancer, PI3K signaling has been extensively studied and is known to promote tumor cell proliferation and contribute to resistance against chemotherapy, making it one of the most frequently dysregulated pathways and a central target in oncologic drug development [17]. Here, PIK3CA is linked to cancer.